Search Results - "Clausen, Anne Skovsbo"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    64Cu-DOTATATE Positron Emission Tomography (PET) of Borrelia Burgdorferi Infection: In Vivo Imaging of Macrophages in Experimental Model of Lyme Arthritis by Skovsbo Clausen, Anne, Ørbæk, Mathilde, Renee Pedersen, Regitze, Oestrup Jensen, Peter, Lebech, Anne-Mette, Kjaer, Andreas

    Published in Diagnostics (Basel) (06-10-2020)
    “…Macrophages play a key role in the inflammatory response in Lyme arthritis (LA) and could be a target for diagnosing and monitoring active Borrelia burgdorferi…”
    Get full text
    Journal Article
  2. 2

    Targeted imaging of uPAR expression in vivo with cyclic AE105 variants by Leth, Julie Maja, Newcombe, Estella Anne, Grønnemose, Anne Louise, Jørgensen, Jesper Tranekjær, Qvist, Katrine, Clausen, Anne Skovsbo, Knudsen, Line Bruhn Schneider, Kjaer, Andreas, Kragelund, Birthe Brandt, Jørgensen, Thomas Jørgen Dyreborg, Ploug, Michael

    Published in Scientific reports (11-10-2023)
    “…A comprehensive literature reports on the correlation between elevated levels of urokinase-type plasminogen activator receptor (uPAR) and the severity of…”
    Get full text
    Journal Article
  3. 3

    Development of a 64Cu-labeled CD4+ T cell targeting PET tracer: evaluation of CD4 specificity and its potential use in collagen-induced arthritis by Clausen, Anne Skovsbo, Christensen, Camilla, Christensen, Esben, Cold, Sigrid, Kristensen, Lotte Kellemann, Hansen, Anders Elias, Kjaer, Andreas

    Published in EJNMMI research (16-09-2022)
    “…Background CD4 + T cells are central inflammatory mediators in the pathogenesis of autoimmune rheumatoid arthritis (RA), as they are one of the dominating cell…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Synthesis and evaluation of hydrogen peroxide sensitive tofacitinib prodrugs by Previtali, Viola, Keiding, Ulrik Bering, Olsen, Asger Hegelund, Peiró Cadahía, Jorge, Clausen, Anne Skovsbo, Kjaer, Andreas, Andresen, Thomas Lars, Hansen, Anders Elias, Clausen, Mads Hartvig

    “…Tofacitinib (CP-690,550), an approved Janus kinase (JAK) inhibitor, has been proven highly efficacious in treating rheumatoid arthritis (RA). Unfortunately,…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10